Xbrane Biopharma AB Market Cap

Xbrane Biopharma AB has a market cap or net worth of 211.20 million as of April 29, 2026. Its market cap has decreased by -29.89% in one year.

Market Cap

211.20M

Enterprise Value

182.92M

Revenue

152.35M

Ranking

n/a

PE Ratio

1.66

Stock Price

9.74

Market Cap Chart

Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 211.20M, an increase of 61.16%. That is a compound annual growth rate of 4.77%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	211.20M	0.49%
Dec 30, 2025	210.17M	-14.54%
Dec 30, 2024	245.94M	-17.28%
Dec 29, 2023	297.31M	-86.83%
Dec 30, 2022	2.26B	-13.94%
Dec 30, 2021	2.62B	58.03%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Initiator Pharma	214.26M
Isofol Medical AB	225.63M
Xintela AB	228.24M
Active Biotech AB	175.30M
AlzeCure Pharma AB	160.31M
Diamyd Medical AB	158.08M
Elicera Therapeutics AB	156.04M
Alligator Bioscience AB	141.32M

Market Cap Rankings